Roger Drew

2.7k total citations
47 papers, 2.1k citations indexed

About

Roger Drew is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Roger Drew has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Roger Drew's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Roger Drew is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Roger Drew collaborates with scholars based in Australia, United States and United Kingdom. Roger Drew's co-authors include John O. Miners, A.R. Bradwell, Lian X. Tang, Mark T. Drayson, Graham P. Mead, Hugh D Carr-Smith, Brian G. Priestly, Donald Birkett, Theodore E. Gram and Zahid H. Siddik and has published in prestigious journals such as Blood, Analytical Biochemistry and British Journal of Cancer.

In The Last Decade

Roger Drew

46 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Drew Australia 18 1.0k 595 479 337 320 47 2.1k
Frederick S. Philips United States 30 1.1k 1.0× 579 1.0× 124 0.3× 111 0.3× 189 0.6× 71 2.6k
Willi Kreis United States 27 1.1k 1.0× 722 1.2× 174 0.4× 91 0.3× 176 0.6× 87 2.4k
L. G. Israels Canada 27 686 0.7× 280 0.5× 289 0.6× 78 0.2× 107 0.3× 82 1.9k
William F. Bale United States 19 754 0.7× 280 0.5× 183 0.4× 133 0.4× 123 0.4× 45 2.3k
Carlo Rumi Italy 26 693 0.7× 430 0.7× 539 1.1× 90 0.3× 165 0.5× 103 2.3k
Sumio Sakamaki Japan 28 1.0k 1.0× 924 1.6× 819 1.7× 81 0.2× 489 1.5× 88 3.3k
Katsuhiko Enomoto Japan 33 2.0k 1.9× 553 0.9× 441 0.9× 121 0.4× 168 0.5× 103 3.8k
Duane A. Tewksbury United States 21 742 0.7× 304 0.5× 157 0.3× 39 0.1× 169 0.5× 47 2.2k
HJ Broxterman Netherlands 19 1.1k 1.0× 1.9k 3.2× 276 0.6× 115 0.3× 60 0.2× 27 2.5k
Cécile Ged France 27 1.8k 1.7× 341 0.6× 149 0.3× 436 1.3× 347 1.1× 94 2.7k

Countries citing papers authored by Roger Drew

Since Specialization
Citations

This map shows the geographic impact of Roger Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Drew more than expected).

Fields of papers citing papers by Roger Drew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Drew. The network helps show where Roger Drew may publish in the future.

Co-authorship network of co-authors of Roger Drew

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Drew. A scholar is included among the top collaborators of Roger Drew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Drew. Roger Drew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeWeese, Theodore L., Roger Drew, Marti Goemann, et al.. (2000). Results of a phase I study of CN706, a replication-competent cytolytic adenovirus, for the treatment of adenocarcinoma of the prostate which is locally-recurrent following radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 48(3). 172–173. 3 indexed citations
2.
Voskoboinik, Ilia, et al.. (1997). Peroxisome proliferators increase the formation of BPDE-DNA adducts in isolated rat hepatocytes. Toxicology. 122(1-2). 81–91. 10 indexed citations
3.
Voskoboinik, Ilia, Roger Drew, & Jorma T. Ahokas. (1997). Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells. Chemico-Biological Interactions. 105(2). 81–97. 4 indexed citations
4.
Voskoboinik, Ilia, Roger Drew, & Jorma T. Ahokas. (1996). Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes. Toxicology Letters. 87(2-3). 147–155. 16 indexed citations
5.
Knights, Kathleen & Roger Drew. (1992). The effects of ibuprofen enantiomers on hepatocyte intermediary metabolism and mitochondrial respiration. Biochemical Pharmacology. 44(7). 1291–1296. 15 indexed citations
6.
Fraunfelder, F. T., D J Coster, Roger Drew, & Frederick W. Fraunfelder. (1990). Ocular Injury Induced by Methyl Ethyl Ketone Peroxide. American Journal of Ophthalmology. 110(6). 635–640. 4 indexed citations
7.
Knights, Kathleen & Roger Drew. (1988). A radioisotopic assay of picomolar concentrations of coenzyme A in liver tissue. Analytical Biochemistry. 168(1). 94–99. 9 indexed citations
8.
Strange, Richard C., William Cotton, Anthony A. Fryer, et al.. (1988). Studies on the expression of Cu,Zn superoxide dismutase in human tissues during development. Biochimica et Biophysica Acta (BBA) - General Subjects. 964(2). 260–265. 30 indexed citations
9.
Drew, Roger, et al.. (1988). Enantiospecific formation of fenoprofen coenzyme a thioester in vitro. Biochemical Pharmacology. 37(19). 3539–3542. 47 indexed citations
10.
Hume, Robert, et al.. (1987). Studies on the developmental expression of glutathione S-transferase isoenzymes in human heart and diaphragm. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 915(3). 371–377. 17 indexed citations
11.
Drew, Roger & John O. Miners. (1984). The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochemical Pharmacology. 33(19). 2989–2994. 238 indexed citations
12.
Miners, John O., Roger Drew, & Donald Birkett. (1984). Effect of cimetidine on paracetamol activation in mice. Biochemical Pharmacology. 33(12). 1996–1998. 8 indexed citations
13.
Miners, John O., John J. Grygiel, Roger Drew, & D. J. Birkett. (1981). Interaction between cimetidine and theophylline in smokers and non-smokers. Clinical and Experimental Pharmacology and Physiology. 8(6). 7 indexed citations
14.
Grygiel, John J., Roger Drew, & John O. Miners. (1981). The effects of cimetidine on theophylline clearance in rat. Clinical and Experimental Pharmacology and Physiology. 8(6). 1 indexed citations
15.
Drew, Roger, et al.. (1981). Species and dose differences in the accumulation of imipramine by mammalian lungs.. Drug Metabolism and Disposition. 9(4). 322–326. 14 indexed citations
16.
Drew, Roger & Zahid H. Siddik. (1980). Effect of a Specific 5HT Uptake Inhibitor (Citalopram) on Drug Accumulation by Rat Lung Slices. Pharmacology. 20(1). 27–31. 6 indexed citations
17.
Mimnaugh, Edward G., et al.. (1979). The effect of unilateral pneumonectomy on in vitro drug metabolism by the contralateral lung of rabbits.. Drug Metabolism and Disposition. 7(4). 208–210. 1 indexed citations
18.
Drew, Roger & Brian G. Priestly. (1978). Failure of hypoactive hypertrophic smooth endoplasmic reticulum to produce cholestasis in rats. Toxicology and Applied Pharmacology. 45(1). 191–199. 5 indexed citations
19.
Drew, Roger, et al.. (1977). Hexobarbital pharmacokinetics in rats after ligation of the common bile duct.. Journal of Pharmacology and Experimental Therapeutics. 201(3). 534–540. 6 indexed citations
20.
Drew, Roger & Brian G. Priestly. (1976). Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts—A lack of correlation. Biochemical Pharmacology. 25(14). 1659–1663. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick S. Philips Breakdown of academic impact, for papers by Willi Kreis Breakdown of academic impact, for papers by L. G. Israels Breakdown of academic impact, for papers by William F. Bale Breakdown of academic impact, for papers by Carlo Rumi Breakdown of academic impact, for papers by Sumio Sakamaki Breakdown of academic impact, for papers by Katsuhiko Enomoto Breakdown of academic impact, for papers by Duane A. Tewksbury Breakdown of academic impact, for papers by HJ Broxterman Breakdown of academic impact, for papers by Cécile Ged
Rankless by CCL
2026